Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population:: the Kalixanda study

被引:73
作者
Aro, P [1 ]
Ronkainen, J
Storskrubb, T
Bolling-Sternevald, E
Carlsson, R
Johansson, SE
Vieth, M
Stolte, M
Engstrand, L
Talley, NJ
Agréus, L
机构
[1] Primary Hlth Care Ctr, SE-95322 Haparanda, Sweden
[2] Karolinska Inst, Ctr Family Med Stockholm, S-10401 Stockholm, Sweden
[3] Kalix Hosp, Kalix, Sweden
[4] AstraZeneca R&D, Molndal, Sweden
[5] Univ Magdeburg, Inst Pathol, D-39106 Magdeburg, Germany
[6] Inst Pathol, Bayreuth, Germany
[7] Inst Infect Dis Control, Stockholm, Sweden
[8] Mayo Clin, Div Gastroenterol & Hepatol, Ctr Enter Neurosci & Translat Epidemiol Res, Rochester, MN USA
关键词
dyspepsia; epidemiology; gastro-oesophageal reflux disease; gastrointestinal symptoms; irritable bowel syndrome; oesophagogastroduodenoscopy; public health; population-based;
D O I
10.1080/00365520410008141
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Upper oesophagogastroduodenoscopy is considered to be the gold standard for upper gastrointestinal disease assessment, but is currently seldom used in epidemiological studies. One concern is that the procedure may bias sampling among volunteers in a general adult population. The aim of this study was to explore whether the procedure affects symptom reporting. Methods: A random sample of 3000 adults aged 20 - 81 years ( mean age 50.4), from two Swedish municipalities (n = 21,610) was surveyed using a validated postal questionnaire ( the Abdominal Symptom Questionnaire) assessing gastrointestinal symptoms. A subsample of the responders was invited, in random order, to undergo an upper endoscopy and repeated symptom reporting using the same questionnaire, as well as a serology test for Helicobacter pylori. Results: The response rate to the initial questionnaire was 74.2% and the participation rate for those eligible for the upper endoscopy was 73.3% ( n = 1001, mean age 54.0 years, 48.8% male). No major social or symptom sampling error was encountered from the selection process, with the exception of an excess of symptom reporters among the youngest subjects. The prevalence of reflux symptoms, dyspeptic symptoms and irritable bowel symptoms was 40%, 37.6% and 29.6%, respectively, which is relatively high, but in no way extreme. Conclusions: The upper endoscopy survey strategy was successful. The response rate was high and there was no major selection bias of clinical relevance. The cohort selected for this study appears to be representative of the general Swedish adult population.
引用
收藏
页码:1280 / 1288
页数:9
相关论文
共 51 条
  • [11] Agreus Lars, 1993, Scandinavian Journal of Primary Health Care, V11, P252, DOI 10.3109/02813439308994840
  • [12] [Anonymous], 1993, Gut, V34, P1672
  • [13] [Anonymous], 1994, FUNCTIONAL GASTROINT
  • [14] Validation of the translation and cross-cultural adaptation into Finnish of the Abdominal Symptom Questionnaire, the Hospital Anxiety and Depression Scale and the Complaint Score Questionnaire
    Aro, P
    Ronkainen, J
    Storskrubb, T
    Bolling-Sternevald, E
    Svärdsudd, K
    Talley, NJ
    Junghard, O
    Johansson, SE
    Wiklund, I
    Agréus, L
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (12) : 1201 - 1208
  • [15] Seroprevalence of Helicobacter pylori in South Sweden and Iceland
    Bergenzaun, P
    Kristinsson, KG
    Thjodleifsson, B
    Sigvaldadottir, E
    Molstad, S
    Held, M
    Wadstrom, T
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 (12) : 1157 - 1161
  • [16] Prevalence of gastroduodenitis and Helicobacter pylori infection in a general population sample -: Relations to symptomatology and life-style
    Borch, K
    Jönsson, KÅ
    Petersson, F
    Redéen, S
    Mårdh, S
    Franzén, LE
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (07) : 1322 - 1329
  • [17] Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15,000 Australian adults
    Bytzer, P
    Howell, S
    Leemon, M
    Young, LJ
    Jones, MP
    Talley, NJ
    [J]. GUT, 2001, 49 (01) : 66 - 72
  • [18] Carlsson R, 1998, SCAND J GASTROENTERO, V33, P1023
  • [19] DROSSMAN DA, 1999, GUT S2, V45
  • [20] Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection
    Ekström, AM
    Held, M
    Hansson, L
    Engstrand, L
    Nyrén, O
    [J]. GASTROENTEROLOGY, 2001, 121 (04) : 784 - 791